Cannabis


Posted on September 07, 2012 by Akashma Online News

Posted by Marivel Guzman

Marijuana, or cannabis, as it is more appropriately called, has been part of humanity’s medicine chest for almost as long as history has been recorded.

Of all the negative consequences of marijuana prohibition, none is as tragic as the denial of medicinal cannabis to the tens of thousands of patients who could benefit from its therapeutic use.

Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief — particularly of neuropathic pain (pain from nerve damage) — nausea, spasticity, glaucoma, and movement disorders. Marijuana is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research suggests that marijuana’s medicinal properties may protect the body against some types of malignant tumors and are neuroprotective.

Currently, more than 60 U.S. and international health organizations support granting patients immediate legal access to medicinal marijuana under a physician’s supervision.

© 2012 NORML and the NORML Foundation. All Rights Reserved
1600 K Street, NW • Mezzanine Level • Washington, DC 20006-2832
Phone: (202) 483-5500 • Fax: (202) 483-0057
  1. March 11, 2015 at 8:00 pm

    US Government Patent on Cannabinoids
    The U.S. Government, as represented by the Department of Health and Human Services (D H H S), filed for a patent on cannabinoids as anti-oxidants and neuroprotectants. U.S. Patent 6630507

    Abstract
    Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuro-protectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Non-psychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuro-protective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH.sub.3, and COCH.sub.3. ##STR1##

    Inventor: Hampson; Aidan J. (Irvine, CA), Axelrod; Julius (Rockville, MD), Grimaldi; Maurizio (Bethesda, MD)
    Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
    Family ID: 26767641
    Appl. No.: 09/674,028
    Filed: February 2, 2001
    PCT Filed: April 21, 1999
    PCT No.: PCT/US99/08769
    PCT Pub. No.: WO99/53917
    PCT Pub. Date: October 28, 1999

    from: http://green-bloom.com/us-government-patent-on-cannabinoids/

    Like

  1. October 2, 2012 at 8:25 pm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: